NTLA Intellia Corp: Bozor kapitallashuvining balans qiymatiga nisbati
Intellia Therapeutics (NTLA) gen terapiyalarini ishlab chiqishga ixtisoslashgan bo'lib, yuqori daromadlilikni ta'minlash uchun in vivo davolashning eksklyuziv huquqlarini qo'lga kiritishga intiladi. Biznes terapevtik usullarni takomillashtirish uchun sanoat yetakchilari bilan strategik sheriklikka tayanadi. Ushbu grafik aksiyalar narxining dinamikasini aks ettiradi, bunda ko'rsatkich quyida ko'rsatilganidek 2.53 darajasida turibdi. Narxlarni belgilash imkoniyatining yo'qligi kompaniyaning baholanishini klinik sinovlarning muvaffaqiyatiga bog'liq qiladi.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_NTLA_-_Intellia-Therapeutics_-_Capitalization-to-Book-Value-Ratio "NTLA: intelliatx.com Bozor qiymatining balans qiymatiga nisbati 04.07.2022 - 29.10.2026 | 👁️GURU.Markets👁️")
Intellia Therapeutics Inc (NTLA) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari
- aksiya kursi va ekspertlarning narx prognozi:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati Intellia Therapeutics|NTLA - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Intellia|NTLA - Kompaniyaning jamlangan qarzi|Qarzning balans qiymatiga nisbati Intellia|NTLA - Uzoq muddatli majburiyatlar miqdori|Kompaniyaning qisqa muddatli qarzlari Intellia Therapeutics|Tezkor likvidlik intelliatx.com
- foyda va bozor multiplikatorlari tafsilotlari:
Kompaniyaning jamlanma tahlili:Intellia Therapeutics, NTLA
Tijorat mahsulotlari yoki joriy pul oqimlarisiz CRISPR platformasini ishlab chiqayotgan Intellia Therapeutics (NTLA) uchun hamkorlarning investitsiyalari asosiy tayanch bo'lib qolmoqda. Kompaniyaning bozor kapitalizatsiyasining uning balans qiymatiga nisbatini tahlil qilish bozor qiymatini haqiqiy sof aktivlar bilan solishtirish imkonini beradi, bu esa investorlarga tebranishlar davrida aksiyaning spekulyativ haddan tashqari qiziganini yoki fundamental jihatdan past baholanganini o'z vaqtida aniqlashga yordam beradi.
Intellia Therapeutics raqobatchilari tahlili
TEM: Bozor kapitallashuvining balans qiymatiga nisbati|qiagen.com (QGEN) - Bozor kapitallashuvining balans qiymatiga nisbati|IONS (Ionis) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati RGEN (Repligen Corp)|Bozor qiymatining balans qiymatiga nisbati Avidity (RNA)|CRISPR - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati WGS (GeneDx Holdings Corp.)|Bozor kapitallashuvining balans qiymatiga nisbati ultragenyx.com RARE|Beam Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Sarepta Therapeutics SRPT|Twist Bio (TWST) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati TXG|Kapitallashuvning sof aktivlarga nisbati STOK|BLFS (biolifesolutions.com) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati WVE|MAZE - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Sionna Pharma SION|Prime Medicine Bio - Bozor qiymatining balans qiymatiga nisbati|TSHA - Bozor qiymatining balans qiymatiga nisbati|QURE: Bozor qiymatining balans qiymatiga nisbati|MGTX: Bozor kapitallashuvining balans qiymatiga nisbati|RGNX - Balans qiymatiga nisbatan bozor kapitallashuvi|SLDB (Solid Bio) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Ocugen Pharma|Kapitallashuvning sof aktivlarga nisbati PACB (Pacific Biosciences)|BNTC (benitec.com) - Balans qiymatiga nisbatan bozor qiymati|Design Therapeutics, Inc. - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori RCKT (Rocket Pharma)|4D Molecular Therapeutics Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati LXEO (Lexeo Therapeutics)|KRRO: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti editasmedicine.com (EDIT)|Bozor qiymatining balans qiymatiga nisbati Silence Therapeutics plc|PRQR: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CDXS|Bozor kapitallashuvining balans qiymatiga nisbati Sangamo BioSciences (SGMO)|Bozor qiymatining balans qiymatiga nisbati Nautilus Bio NAUT|MGX (metagenomi.co) - Sof aktivlarga nisbatan bozor kapitallashuvi|Precision BioSciences - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Generation Bio Co.|BOLD (Boundless Bio, Inc) - Kapitallashuvning sof aktivlarga nisbati|Exicure (XCUR) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati IMNN|PHIO (RXi Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati MBIO|Balans qiymatiga nisbatan bozor kapitallashuvi transcodetherapeutics.com|Bozor kapitallashuvining balans qiymatiga nisbati BNGO (Bionano Genomics)|APDN - Kapitallashuvning sof aktivlarga nisbati|BLUE - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi ImmunoPrecise Antibodies IPA|Omega Therapeutics, Inc. (OMGA) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati OMIC|Kapitallashuvning sof aktivlarga nisbati RGLS|SYRS (Syros Pharmaceuticals, Inc) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor qiymatining balans qiymatiga nisbati Telesis Bio, Inc. (TBIO)|Bozor qiymatining balans qiymatiga nisbati TCON (traconpharma.com)|Bozor kapitallashuvining balans qiymatiga nisbati UBX (Unity Biotechnology, Inc.)